Results 11 to 20 of about 3,024,430 (309)
, 2011 Ficha Técnica Volume 16 - Nº 2 - 2º Quadrimestre de ...
Volume 16 - Nº 3 - 2011, Ficha Técnica +1 more
core +2 more sources
OASIcs, Volume 53, CMN'16, Complete Volume [PDF]
, 2016 OASIcs, Volume 53, CMN'16, Complete ...
Finlayson, Mark A. +4 more
core +1 more source
LIPIcs, Volume 51, SoCG'16, Complete Volume [PDF]
, 2016 LIPIcs, Volume 51, SoCG'16, Complete ...
Lubiw, Anna, Fekete, Sándor
core +1 more source
OASIcs, Volume 51, SLATE'16, Complete Volume
, 2016 OASIcs, Volume 51, SLATE'16, Complete ...
Gonçalo Oliveira, Hugo +2 more
core +1 more source
LIPIcs, Volume 64, ISAAC'16, Complete Volume [PDF]
, 2016 LIPIcs, Volume 64, ISAAC'16, Complete ...
Hong, Seok-Hee
core +1 more source
LIPIcs, Volume 55, ICALP'16, Complete Volume [PDF]
, 2016 LIPIcs, Volume 55, ICALP'16, Complete ...
Mitzenmacher, Michael +3 more
core +1 more source
OASIcs, Volume 16, MEMICS'10, Complete Volume
, 2012 OASIcs, Volume 16, MEMICS'10, Complete ...
Vojnar, Tomáš +4 more
core +1 more source
LIPIcs, Volume 57, ESA'16, Complete Volume [PDF]
, 2016 LIPIcs, Volume 57, ESA'16, Complete ...
Zaroliagis, Christos, Sankowski, Piotr
core +1 more source
LIPIcs, Volume 16, CSL'12, Complete Volume
, 2013 LIPIcs, Volume 16, CSL'12, Complete ...
Cégielski, Patrick, Durand, Arnaud
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Central nervous system (CNS) involvement in childhood acute lymphoblastic leukemia (ALL) is assessed by cell counting and cytomorphology from cerebrospinal fluid (CSF) and is used for treatment stratification worldwide. The ratio of “CNS2” patients in clinical trials ranges from 3% to 40%, with unclear prognostic significance ...
Laura Almási +14 more
wiley +1 more source